The risk of early death beyond 12 years of age related to teenage pregnancies and gestational age.
Updated: Lilly boosts sales guidance by $2B, but GLP-1 supply constraints still a focus
Eli Lilly is expecting supply disruptions for its blockbuster weight loss and diabetes products to continue through the end of this year, executives told investors.